Interventions for basal cell carcinoma of the skin

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2007, Pages

  Bath Hextall, Fiona J ^a   Perkins, W ^b   Bong, J ^b   Williams, H C ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NONE

Author keywords

Adult; Antineoplastic agents therapeutic use ; Carcinoma, basal cell surgery; *therapy ; Cryotherapy; Humans; Photochemotherapy; Radiotherapy; Randomized controlled trials as topic; Skin neoplasms surgery; *therapy ; Treatment outcome

Indexed keywords

ADRENALIN; ALPHA2A INTERFERON; ALPHA2B INTERFERON; BEC 5; BETA INTERFERON; FLUOROURACIL; IMIQUIMOD; PLACEBO; SOLASODINE; VERTEPORFIN;

ANOREXIA; ARTHRALGIA; BASAL CELL CARCINOMA; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CHEMOSURGERY; CLINICAL TRIAL; COCHRANE LIBRARY; CRYOSURGERY; DIARRHEA; DIZZINESS; DOSAGE SCHEDULE COMPARISON; EMBASE; FATIGUE; FEVER; HEADACHE; HUMAN; INTERVENTION STUDY; MALAISE; MEDLINE; MYALGIA; NAUSEA; PARESTHESIA; RASH; REVIEW; RIGOR; SIDE EFFECT; SINGLE DRUG DOSE; SKIN CARCINOMA; SKIN MANIFESTATION; SOMNOLENCE; THIRST; UNSPECIFIED SIDE EFFECT; VOMITING;

EID: 36849082229     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003412.pub2     Document Type: Review

References (71)

1. Alpsoy 1996 {published data only} *Alpsoy E, Yikmaz E, Basaran E, Yazar S. Comparison of the effects of intralesional interferon alfa-1a, 2b and the combination of 2a and 2b in the treatment of basal cell carcinoma. The Journal of Dermatology 1996;23:394-6.
2. Avril 1997 {published data only} *Avril MF, Auperin A, Margulis A, Gerbaulet A, Duvillard P, Benhamou E, et al.Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. British Journal of Cancer 1997; 76(1):100-6.
3. Petit JY, Avril MF, Margulis A, Chassagne D, Gerbaulet A, Duvillard P, et al.Evaluation of cosmetic results of a randomised trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face. Plastic and Reconstructive Surgery 2000;105(7):2544-51.
4. Basset-Sequin 2005 {published data only} Basset-Sequin N, Ibbotson S, Emtestam L. Photodynamic therapy using aminolevulinate is as efficacious as cryotherapy in basal cell carcinoma, with better results. British Association of Dermatologists 83rd Annual Meeting. 2003; Vol. 149(Suppl.64):46.
5. *Basset-Sequin N, Ibbotson S, Emtestam L, Tarstedt M, Morton C, Maroti M, et al.Methyl aminolaevulinate photodynamic therapy vs cryotherapy in primary superficial basal cell carcinoam: results of a 36 month follow-up. British Journal of Dermatology. 2005; Vol. 153 (Suppl 1):29.
6. Beutner 1999 {published data only} Beutner KR, Geisse JK, Helman D, Fox TL, Ginkel A, Owens MA. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. Journal of the American Academy of Dermatology 1999;41:1002-7.
7. Cornell 1990 {published data only} Cornell RC, Greenway HT, Tucker SB, Edwards L, Ashworth S, Vance JC, et al.Intralesional interferon therapy for basal cell carcinoma. Journal of the American Academy of Dermatology 1990;23:694-700.
8. Edwards 1990 {published data only} Edwards L, Tucker SB, Perednia D, Smiles KA, Taylor EL, Tanner DJ, et al.The effects of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinoma. Archives of Dermatology 1990;126:1029-32.
9. Foley 2003 {published data only} Foley P, Freeman M, Siller G, Gebauer K, Murrell D, Barnetson R, et al.A phase III randomized study comparing photodynamic therapy (PDT) using methyl aminolevulinate or placebo cream in nodular basal cell carcinoma (NBCC). Journal of the European Academy of Dermatology and Venereology. 2003; Vol. 17(Suppl 3):231.
10. Geisse 2002 {published data only} Geisse JK, Marks R, Owens ML, Andres K, Ginkel AM. Imquimod 5% cream for 12 weeks treating suprficial BCC. The 8th World Congress on Cancer of the Skin, Zurich, Switzerland. July 18-21, 2001.
11. *Geisse JK, Rich P, Pandya A, Gross K, Andres K, Ginkel A, et al.Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: A randomized, vehicle-controlled study. Journal of the American Academy of Dermatology 2002;47:390-8.
12. Geisse 2004 {published data only} Geisse J, Caro I, Lindholm J, Golitz L, Stampone P, Owens M. Imiquimod 5% cream for the treatment of superfical basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. Journal of the American Academy of Dermatology 2004;50:722-33.
13. Hall 1986 {published data only} Hall VL, Leppard BJ, McGill J, Kesseler ME, White JE, Goodwin P. Treatment of basal cell carcinoma: comparison of radiotherapy and cryotherapy. Clinical Radiology 1986;37:33-4.
14. Lui 2004 {published data only} Lui H, Hobs L, Tope WD, Lee PK, Elmets C, Provost N, et al.Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes. Archives of Dermatology 2004;140:26-32.
15. Marks 2001 {published data only} Marks R, Gebauer K, Shumack S, Amies M, Bryden J, Fox TL, et al.Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicentre 6-week dose-response trial. Journal of the American Academy of Dermatology 2001;44:807-13.
16. Miller 1997 {published data only} Miller BH, Shavin JS, Cognetta A, Richard Taylor J, Salasche S, Korey A, et al.Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel. Journal of the American Academy of Dermatology 1997;36:72-7.
17. Punjabi 2000 {published data only} Punjabi S, Cook LJ, Kersey P, Finlay A, Sharp G, Roberts D, et al.A double-blind, multicentric parallel group study of BEC-5 cream in basal cell carcinoma (BCC). European Academy of Dermatology and Venereology. 2000; Vol. 14(Suppl.1):49.
18. Rhodes 2004 {published data only} Rhodes LE, de Rie M, Enstrom Y, Groves R, Morken T, Goulden V, et al.Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma. Archives of Dermatology 2004;140:17-13.
19. Rogozinski 1997 {published data only} Rogozinski TT, Jablonska S, Brzoska IM, Wohr C, Gaus W. [Doogniskowe podawanie rekombinantowego interferonu beta. Skuteczna alternatywa w leczeniu basalimoma (wyniki podwojnie slepej proby)]. Przegla¿d dermatologiczny 1997;84(3):259- 63.
20. Romagosa 2000 {published data only} Romagosa R, Saap L, Givens M, Salvarrey A, He JL, Hsia SL, et al.A pilot study to evaluate the treatment of basal cell carcinoma with 5-fluorouracil using phosphatidyl choline as a transepidermal carrier. Dermatological Surgery 2000;26:338- 40.
21. Schulze 2005 {published data only} Schulze HJ, Cribier B, Requena L, Reifenberger J, Ferrandiz C, Diez G, et al.Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. British Journal of Dermatology 2005;152:939-47.
22. Shumack 2002a {published data only} Shumack S, Marks R, Amies M, Andres K, Ginkel AM. Imiquimod 5% cream for 6 weeks treating nodular BCC. The 8th World Congress on Cancers of the Skin, Zurich, Switzerland. July 18-21, 2001.
23. *Shumack S, Robinson J, Kossard S, Golitz L, Greenway H, Schroeter A, et al.Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma. Archives of Dermatology 2002;138: 1165-71.
24. Shumack 2002b {published data only} Robinson JK, Marks R, Owens ML, Andres K, Ginkel AM. Imiquimod 5% cream for 12 weeks treating nodular BCC. The 8th World Congress on Cancer of the Skin, Zurich, Switzerland. July 18-21, 2001.
25. *Schumack S, Robinson J, Kossard S, Golitz L, Greenway H, Schroeter A, et al.Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma. Archives of Dermatology 2002;138:1165-71.
26. Smeets 2004 {published data only} Smeets NWJ, Krekels GAM, Ostertag JU, Essers BAB, Dirksen CD, Nieman FHM, et al.Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 2004;364:1766-72.
27. Soler 2000 {published data only} Soler AM, Angell-Petersen E, Warloe T, Tausjo J, Steen HB, Moan J, et al.Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: A comparison of two light sources. Photochemistry and Photobiology 2000;71(6):724-9.
28. Sterry 2002 {published data only} Sterry W, Bichel J, Andres K, Ginkel AM. Imiquimod 5% cream for 6 weeks with occlusion treating superficial BCC. The 8th World Congress on cancers of the skin, Zurich, Switzerland. July 18-21, 2001.
29. Sterry W, Bichel J, Ding L, Ginkel AM. Imiquimod 5% cream for 6 weeks with occlusion treating nodular BCC. The 8th World Congress on Cancer of the skin, Zurich, Switzerland. July 18-21, 2001.
30. *Sterry W, Ruzicka T, Herrera E, Takwale A, Bichel J, Andres K, et al.Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. British Journal of Dermatology 2002;147:1227-36.
31. Thissen 2000 {published data only} Thissen MRTM, Nieman FHM, Ideler AHLB. Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. Dermatological Surgery 2000; 26:759-64.
32. Tope 2005 {published data only} *Tope WD, Menter A, El Azhary R, Soto P. A comparison of topical MAL-PDT versus placebo-PDT in nodular basal cell carcinoma: results of a North American study. 7th Asian Congress of Dermatology incorporating the 5th Regional Conference of Paediatric Dermatology; Kuala Lumpur, Malaysia. 2005, issue c2005:376.
33. Tope WD, Menter A, El-Azhary RA. Randomized prospective comparison of topical mehtylaminolevulinate phodynamic therapy versus placebo photodynamic therapy in nodular basal cell carcinoma. 9th World Congress of Cancers of the Skin, Seville. 2003.
34. Wang 2001 {published data only} Wang I, Bendsoe N, Klinteberg CAF, Enejder AMK, Andersson-Engels S, Svanberg S, et al.Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. British Journal of Dermatology 2000;144:832-40.
35. Bunker 2000 Bunker C. 5 Fluoracil/Adrenaline injectable gel in basal cell carcinoma. National Research Register.
36. Enejder 2000 Enejder AMK, Klinteberg C, Wang I, Andersson-Engels S, Bendsoe N, Svanberg S, et al.Blood perfusion studies on basal cell carcinomas in conjunction with photodynamic therapy and cryotherapy employing laser-doppler perfusion imaging. Acta dermato-venereologica 2000;80:19-23.
37. Griffiths 2000 Griffiths CEM. A double-blind, vehicle controlled, randomised, parallel group study to assess the efficacy and safety of BEC-5 in the treatment of patients with basal cell carcinoma. National Research Register.
38. MacKie 2000 MacKie RM. A prospective randomised multicentre phase 3 study of photodynamic therapy using methyl 5-aminolaevulinate cream in comparison with cryotherapy in patients with superficial basal cell carcinomas. National Research Register.
39. Mallon 1996 Mallon E, Dawber R. Cryosurgery in the treatment of basal cell carcinoma. Dermatological Surgery 1996;22:854-8.
40. McGregor 2000 McGregor J. Topical imiquimod for treatment of BCCs. National Research Register.
41. Rustin 2000 Rustin MHA. A double-blind vehicle controlled randomised parallel group study to assess the efficacy and safety of BEC-5 in the treatment of basal cell carcinoma. National Research Register.
42. Groves 2000 Multicentre phase III randomised study of photodynamic therapy with cream A in comparison with simple excision surgery in patients with primary nodular basal cell carcinoma.. Ongoing study Starting date of trial not provided. Contact author for more information.
43. SINS SINS (Surgery versus Imiquimod for Nodular and Superficial basal cell carcinoma). Prospective, three-centre, randomised controlled phase III trial, to compare excision surgery and imiquimod cream for nodular and superficial basal cell carcinoma presenting on either the trunk or in low risk areas on the head.. Ongoing study Starting date of trial not provided. Contact author for more information.
44. Altman 1991 Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1991.
45. Breuninger 1991 Breuninger H, Dietz K. Prediction of subclinical tumor infiltration in basal cell carcinoma. Journal of Dermatologic Surgery and Oncology 1991;17:574-8.
46. Census 1988 Office of population census and surveys 1984 cancer statistic Regulations. London:HMSO, 1988.
47. Chuang 1990 Chuang TY, Popescu NA, Su D, Chute CG. Basal cell carcinoma, a population-based incidence study in Rochester, Minnesota. Journal of the American Academy of Dermatology 1990;22:413-7.
48. Franchimont 1982 Franchimont C. Episodic progression and regression of basal cell carcinomas. British Journal of Dermatology 1982;106:305-10.
49. Gilbody 1994 Gilbody JS, Aitken J, Green A. What causes basal cell carcinoma to be the commonest cancer?. Australian Journal of Public Health 1994; 18:218-21.
50. Government 1997 Department of Health. The New NHS. Modern. Dependable. London. The Stationery Office Ltd 1997; Vol. Clause 1.13.
51. Higgins 2005 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [Updated May 2005]. The Cochrane Library 2005, Issue 3.
52. Johnson 1996 Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, et al.Human Homolog of patched, a candidate gene for the Basal Cell Nevus Syndrome. Science 1996;272:1668-71.
53. Lo 1991 Lo JS, Snow SN, Reizner GT. Metastatic basal cell carcinoma report of twelve cases with a review of the literature. Journal of the American Academy of Dermatology 1991;24:715-19.
54. Mackie 1987 Mackie RM, Elwood JM, Hawk JLM. Links between exposure to ultraviolet radiation and skin cancer. A report of the Royal College of Physicians. Journal of the Royal College of Physicians London 1993; 29:91-6.
55. May 1981 May GS, Demets DL, Friedman LM, Furberg C, Passamani E. The randomized clinical trial:bias in analysis. Circulation 1981;64:669-73.
56. McCormack 1997 McCormack CJ, Kelly JW, Dorevitch AP. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma: a possible indicator of differing causes. Archives of Dermatology 1997;133:593-6.
57. Miller 1991 Miller SJ. Biology of basal cell carcinoma (part 1). Journal of the American Academy of Dermatology 1991;24:1-13.
58. Orenberg 1992 Orenberg EK, Miller BH, Greenway HT. The effect of intralesional 5-fluorouracil therapeutic implant (MP1 5003) for treatment for basal cell carcinoma. Journal of American Academy of Dermatology 1992;27:723-8.
59. Pearl 1986 Pearl DK, Scott EL. The anatomical distribution of skin cancers. International Journal of Epidemiology 1986;15:502-6.
60. Petit 2000 Petit JY, Avril MF, Margulis A, Chassagne D, Gerbaulet A, Duvillard P, et al.Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face. Plastic and Reconstructive Surgery 2000;105(7):2544-51.
61. Preston 1992 Preston DS, Stern RS. Nonmelanoma cancers of the skin. New England Journal of Medicine 1992;327:1649-62.
62. Raasch 2002 Raasch BA, Buettner PG. Multiple nonmelanoma skin cancer in an exposed Australian population. International journal of Dermatology 2002;41(10):652-8.
63. Roenigk 1986 Roenigk RK, Ratz JL, Bailin PL, Wheeland RG. Trends in the presentation and treatment of basal cell carcinomas. Journal of Dermatologic Surgery and Oncology 1986;12:860-5.
64. Sackett 1979 Sackett DL, Gent M. Controversy in counting and attributing events in clinical trials. New England Journal of Medicine 1979;301:1410-12.
65. Schreiber 1990 Schreiber MM, Moon TE, Fox SH, Davidson J. The risk of developing subsequent nonmelanoma skin cancers. Journal of the American Academy of Dermatology 1990;23:1114-18.
66. Schulz 1995 Schulz KF, Chalmers I, Hayes RJ. Empirical evidence of bias. Journal of the American Medical Academy 1995;273:408-12.
67. Staples 1998 Staples M, Marks R, Giles G. Trends in the incidence of nonmelanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect?. International Journal of Cancer 1998;78:144-8.
68. Telfer 1999 Telfer NR, Colver GB, Bowers PW. Guidelines for the management of basal cell carcinoma. British Journal of Dermatology 1999;141:415-23.
69. Thissen 1998 Thissen MR, Neumann HA, Berretty PJ, Ideler AH. [Behandeling van het basalecelcarcinoon door dermatogogen in Nederland]. Ned Tijdschr Geneeskd 1998;142:1563-67.
70. Thissen 1999 Thissnen MRTM, Neumann HA, Schouten LJ. A systematic review of treatment modalities for primary basal cell carcinoma. Archives of Dermatology 1999;135:1177-83.
71. Zaynoun 1985 Zaynoun S, Ali LA, Shaib J. The relationship of sun exposure and solar elastosis to basal cell carcinoma. Journal of the American Academy of Dermatology 1985;12:522-25.